{
  "criteria": [
      {
          "section": "1",
          "option": "1A",
          "score": 0.0,
          "reason": "The number of overlapping protein-coding genes (39) or enhancers (164) is more than zero.",
          "evidence": "1A. Contains protein-coding or other known functionally important elements"
      },
      {
          "section": "2",
          "option": "2G",
          "score": 0.0,
          "reason": "Overlaps 3 established benign CNV, but contains additional protein coding genes. Benign CNVs:\nAccession number: gssvG12662, pubmedid: UNKNOWN. Overlap: 8872bp (0.6%).\nAccession number: gssvG12662, pubmedid: UNKNOWN. Overlap: 8872bp (0.6%).\nAccession number: gssvG12662, pubmedid: UNKNOWN. Overlap: 8872bp (0.6%).",
          "evidence": "2G. Overlaps a benign copy number gain but includes additional genomic material"
      },
      {
          "section": "3",
          "option": "3B",
          "score": 0.45,
          "reason": "Overlaps 39 protein-coding genes.",
          "evidence": "3B. 35-49 genes"
      },
      {
          "section": "4",
          "option": "4Skip",
          "score": 0.0,
          "reason": "Manual decision needed.",
          "evidence": "Skip if there have been no reports associating either the copy number gain or any of the genes therein with human phenotypes caused by triplosensitivity"
      },
      {
          "section": "5",
          "option": "5F",
          "score": 0.0,
          "reason": "No family history is available.",
          "evidence": "5F. Inheritance information is unavailable or uninformative."
      }
  ],
  "score": 0.45,
  "severity": "Uncertain"
}
